Results, reports, presentations and circulars

Date Title Statement Presentation Report Webcast
21 October 2019

Phase 2b Symptom data with Nebulized Ensifentrine at CHEST 2019

  Presentation    
30 September 2019

Interim Phase 2 DPI data at ERS 2019

  Presentation    
20 May 2019

Expanded Analysis of Clinical Data at ATS 2019

  Presentation    
8 May 2019

Investor and Analyst R&D Forum

  Presentation    
26 February 2019

2018 Annual Report

    Report  
12 February 2019

Verona Pharma BIO CEO & Investor Feb 2019 Presentation

  Presentation    
14 January 2019

Top-line data from add-on to LABA/LAMA/ICS study

  Presentation    
10 January 2019

Verona Pharma JP Morgan Presentation

  Presentation    
Close

Verona Pharma plc
3 More London Riverside, London SE1 2RE
T: +44 (0)203 283 4200

Linkedin     Email Us